As of July 2026, 210 paid clinical trials are recruiting for Oncology in New Haven, Connecticut. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
New Haven has approximately 851 recruiting research studies across a wide range of therapeutic areas. Connecticut hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Researchers run research studies in New Haven, CT at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Yale University | Acute Myeloid Leukemia, Alcohol Use Disorder, Stage IV Lung Cancer AJCC v8 | 247 |
| Yale Cancer Center | Advanced Solid Tumor, Advanced Solid Tumors, NSCLC | 69 |
| Yale New Haven Hospital | Ischemic Stroke, Multiple Myeloma, NAFLD | 61 |
| Yale University School of Medicine | Alzheimers Disease, Alzheimers Disease, Familial, Colorectal Cancer | 60 |
| Yale School of Medicine | Epilepsy, Epilepsy (Treatment Refractory), Hemoglobinopathies | 42 |
| Smilow Cancer Center/Yale-New Haven Hospital | Ovarian Carcinoma, Advanced Hepatocellular Carcinoma, Anatomic Stage I Breast Cancer AJCC v8 | 19 |
| Connecticut Mental Health Center | Borderline Personality Disorder, Alcohol Use, Alcohol Use Disorder | 12 |
| Yale | AML, MDS, Acute Gastrointestinal Bleeding | 12 |
| Yale-New Haven Hospital | Acute Ischemic Stroke, Acute Myeloid Leukemia, Anemia, Sickle Cell | 12 |
| GSK Investigational Site | HIV Infections, Colonic Neoplasms, Gastrointestinal Neoplasms | 8 |
| Smilow Cancer Hospital at Yale New Haven | Advanced Solid Tumor, AML, AML With Mutated NPM1 | 8 |
| Yale Child Study Center | Speech, Anxiety Disorder of Adolescence, Autism | 8 |
| Yale New Haven Health | Chronic Kidney Diseases, Claudication, Critical Limb Ischemia | 7 |
| Musical Intervention Studios | COVID-19, Mental Health Issue, Alzheimer Disease | 6 |
| Smilow Cancer Hospital | Cancer, Sickle Cell Disease, Glioma, Malignant | 6 |
| Yale University, Yale Cancer Center | Breast Cancer, Endometrial Cancer, Ovarian Cancer | 6 |
| BLOOM | COVID-19, Mental Health Issue | 5 |
| Yale New Haven Health System | Aortic Stenosis, Heart Failure, ATTR Amyloidosis With Cardiomyopathy | 5 |
| Yale University Cancer Center | Advanced Solid Tumor, Advanced Solid Tumors, Anal Squamous Cell Carcinoma | 5 |
| Smilow Cancer Hospital - Yale New Haven Health | Breast Cancer, Advanced Non-Small Cell Lung Cancer, Advanced/Metastatic Solid Tumors | 4 |
| Yale New Haven Children's Hospital | Antibiotic Stewardship, Failed or Difficult Intubation, Sequela, Intubation Complication | 4 |
| Yale University School Of Medicine | Colorectal Neoplasms, Healthy Volunteers, Irritability Associated With Autism Spectrum Disorder | 4 |
| Yale University Yale Cancer Center | Advanced Solid Tumor, Advanced Solid Tumors, B Cell Lymphoma | 4 |
| Yale-New Haven Hospital-Yale Cancer Center | Advanced Breast Cancer, Breast Cancer, CRC | 4 |
| Clinical Trial Site | Generalized Myasthenia Gravis, Lichen Planopilaris, Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL) | 3 |
Recruiting trials in New Haven grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Connecticut are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Connecticut research additionally follows state public health department oversight and any applicable state privacy statutes.
Hipa.ai aggregates every recruiting study in New Haven from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 851 recruiting clinical trials in New Haven, Connecticut listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in New Haven compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in New Haven include Advanced Solid Tumor (22), Breast Cancer (18), Alcohol Use Disorder (16), Acute Myeloid Leukemia (12), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New Haven on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in New Haven include Yale University, Yale Cancer Center, Yale New Haven Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in New Haven are Cancer & tumors (309), Neurology & pain (45), Cardiovascular (40). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.